08/08/2013 - 4:04pm

The world is turning generic. That's the takeaway from the latest trends in the drug industry, according to IMS Health.

08/08/2013 - 4:04pm

The urgency behind Diplomat's launch of its Retail Specialty Network isn't hard to fathom. As the growth momentum in pharmaceuticals shifts from traditionally developed drugs to more complex and expensive specialty and biotech products, traditional pharmacies without access to these specialized medicines — and the patients who depend on them — find themselves stranded in a receding market like boats at low tide.

08/08/2013 - 4:04pm

Can one of the nation's premier specialty pharmacies maintain its focus on each patient it serves while simultaneously smashing its own growth records and reaching national power-player status in the rarified world of specialized medication services?

08/06/2013 - 12:33pm

Hospira posted sales of $1 billion during second quarter 2013, a 0.7% decrease compared with second quarter 2012, the generic drug maker said.

08/06/2013 - 12:01pm

Mylan's sales ticked up slightly in second quarter 2013, compared with the same period last year, the company said.

08/06/2013 - 10:52am

The Food and Drug Administration has approved a generic heart disease drug made by Lupin, the Indian drug maker said.

08/05/2013 - 8:58am

Amneal Pharmaceuticals has introduced five new generic drugs, the company said.

08/02/2013 - 1:05pm

The Senate was expected to take up a bill designed to secure the drug supply chain and establish a list of "do not compound" medications, but left for recess Friday without voting on it.

07/31/2013 - 12:57pm

The Food and Drug Administration has given Lupin Pharmaceuticals tentative approval to two of its products, the company said Wednesday.